Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary g...
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
About this item
Full title
Author / Creator
Nagler, Arnon , Labopin, Myriam , Swoboda, Ryszard , Kulagin, Alexander , Velardi, Andrea , Sanz, Jaime , Labussière-Wallet, Hélène , Potter, Victoria , Kuball, Jürgen , Sica, Simona , Parovichnikova, Elena , Bethge, Wolfgang , Maillard, Natacha , Platzbecker, Uwe , Stölzel, Friedrich , Ciceri, Fabio and Mohty, Mohamad
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Second transplantation (HSCT2) is a potential treatment for primary graft failure (pGF). We assessed the outcome of HSCT2, performed between 2000 and 2021, for pGF in 243 patients with acute leukemia. Median age was 44.8 years. Conditioning at first HSCT (HSCT1) was myeloablative (MAC) in 58.4%. Median time from HSCT1 to HSCT2 was 48 days. Donors f...
Alternative Titles
Full title
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2821343064
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2821343064
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/s41409-023-02012-5
